Literature DB >> 21320970

Limbal allograft transplantation using fibrin glue.

Nariman Nassiri1, Hemang K Pandya, Ali R Djalilian.   

Abstract

Limbal transplantation is now widely accepted as the treatment of advanced limbal stem cell deficiency. Herein, we describe a technique for harvesting thin limbal grafts from cadaveric corneoscleral rims and a sutureless method to secure the grafts to the recipient eye using fibrin glue. We report the results of fibrin glue-assisted keratolimbal allograft in 19 eyes of 16 patients, with the outcome measures being ocular surface stability, visual acuity, and postoperative complications. The results indicate that limbal allograft transplantation can be performed safely and successfully using only fibrin glue to secure the grafts. This can potentially improve surgical efficiency and patient comfort postoperatively.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320970     DOI: 10.1001/archophthalmol.2010.370

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  11 in total

1.  Fibrin glue inhibits migration of ocular surface epithelial cells.

Authors:  A M Yeung; L A Faraj; O D McIntosh; V K Dhillon; H S Dua
Journal:  Eye (Lond)       Date:  2016-07-01       Impact factor: 3.775

Review 2.  The application of human amniotic membrane in the surgical management of limbal stem cell deficiency.

Authors:  Qihua Le; Sophie X Deng
Journal:  Ocul Surf       Date:  2019-01-08       Impact factor: 5.033

3.  Diagnostic criteria for limbal stem cell deficiency before surgical intervention-A systematic literature review and analysis.

Authors:  Qihua Le; Tulika Chauhan; Sophie X Deng
Journal:  Surv Ophthalmol       Date:  2019-07-02       Impact factor: 6.048

4.  Novel implantable composite biomaterial by fibrin glue and amniotic membrane for ocular surface reconstruction.

Authors:  Mingming Cai; Jie Zhang; Lili Guan; Min Zhao
Journal:  J Mater Sci Mater Med       Date:  2015-03-13       Impact factor: 3.896

5.  Late Acute Rejection After Allograft Limbal Stem Cell Transplantation: Evidence for Long-Term Donor Survival.

Authors:  Medi Eslani; Zeeshan Haq; Asadolah Movahedan; Adam Moss; Alireza Baradaran-Rafii; Gautham Mogilishetty; Edward J Holland; Ali R Djalilian
Journal:  Cornea       Date:  2017-01       Impact factor: 2.651

Review 6.  Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

Authors:  Alireza Baradaran-Rafii; Medi Eslani; Zeeshan Haq; Ebrahim Shirzadeh; Michael J Huvard; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-09-17       Impact factor: 5.033

7.  Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency.

Authors:  Alexandra Norrick; Jasmina Esterlechner; Elke Niebergall-Roth; Markus H Frank; Mark A Kluth; Ulf Dehio; Samar Sadeghi; Hannes M Schröder; Seda Ballikaya; Nicole Stemler; Christoph Ganss; Kathrin Dieter; Ann-Kathrin Dachtler; Patrick Merz; Saadettin Sel; James Chodosh; Claus Cursiefen; Natasha Y Frank; Gerd U Auffarth; Bruce Ksander
Journal:  Stem Cell Res Ther       Date:  2021-03-19       Impact factor: 6.832

8.  Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation.

Authors:  Nadia Zakaria; Tine Possemiers; Sorcha Ní Dhubhghaill; Inge Leysen; Jos Rozema; Carina Koppen; Jean-Pierre Timmermans; Zwi Berneman; Marie-Jose Tassignon
Journal:  J Transl Med       Date:  2014-03-03       Impact factor: 5.531

Review 9.  Transforming ocular surface stem cell research into successful clinical practice.

Authors:  Virender S Sangwan; Rajat Jain; Sayan Basu; Anupam B Bagadi; Shraddha Sureka; Indumathi Mariappan; Sheila Macneil
Journal:  Indian J Ophthalmol       Date:  2014-01       Impact factor: 1.848

Review 10.  The ocular surface chemical burns.

Authors:  Medi Eslani; Alireza Baradaran-Rafii; Asadolah Movahedan; Ali R Djalilian
Journal:  J Ophthalmol       Date:  2014-07-01       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.